Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients. - Wikidata - awgldk - TriplyDB

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

http://www.wikidata.org/entity/Q34102506

about

State of the art: Response assessment in lung cancer in the era of genomic medicine The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review.PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies.Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario.Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxel Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix.Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates.Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates.Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New Developments.Why are we failing to implement imaging studies with radiolabelled new molecular entities in early oncology drug development?An innovative iterative thresholding algorithm for tumour segmentation and volumetric quantification on SPECT images: Monte Carlo-based methodology and validation.Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation.A bivalent small molecule-drug conjugate directed against carbonic anhydrase IX can elicit complete tumour regression in mice

P2860

Q34681069-6442C83C-A3B1-4822-A7CF-850237BCF142 Q36294460-B7B3A839-A06B-4666-A3CA-D757463A220C Q36382576-3A993C02-E90A-458F-835C-1DD939B7447B Q36953090-19855386-30A0-4ABC-9E76-73C1E49B0F5C Q37217782-15FFC698-A478-4282-A281-4C22472FB812 Q37559487-ED9242A2-7341-462A-9CC1-1F9F8165A875 Q37559740-807449E5-68CF-4C50-A5BD-84DD45A309CE Q37606966-BDBF854E-627E-4D81-BC31-AD7365FE027D Q38066590-990DA9B9-9F56-42CA-8A9C-CC65B891864A Q38132396-76168918-E225-430C-A394-7FDF611B59F4 Q38726647-5D11EC33-8BD5-4C8B-AAE1-374CB1EED27C Q38842103-4BC3C4EE-29B2-4ABD-BBEC-C665FDDF70CD Q47745329-060BA5CA-FE8C-488E-8DD6-68D8CE0009B4 Q48199774-8EFCB0F3-1535-4C0B-AD4C-2C0D95179F7C Q48226060-23695CA0-8691-4B72-B109-47BE6FF03346 Q48849601-69BE474E-D3DF-45FC-A4B4-3ECC351FD05D Q50084824-F8739FA6-A652-4665-B52B-C354296A02CD Q51207076-F97FFE03-1A21-40E1-8532-AF64BA230C72 Q51542387-33D69730-04BD-4ABC-BE1B-9CE9CEAC309E Q52763843-B34F323E-081E-438F-9A79-6812F7D3E465 Q57911942-7F895C99-5E13-4BBF-8BB6-EE8ADA4E7D07

P2860

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

http://www.wikidata.org/entity/Q34102506

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@ast

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@en

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@nl

type

label

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@ast

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@en

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@nl

prefLabel

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@ast

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@en

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@nl

P1433

Q34102506-84C43FC6-35A3-408B-8C70-0DBD79B0E16C

P1476

Q34102506-6D5F7BC5-629C-4D98-B624-972020A29223

P2093

Q34102506-32D5746F-3834-4393-9DFB-035C4BC7DF83

Q34102506-51368A5E-85DF-4F68-8055-6C340D187B86

Q34102506-5F5BB3E4-BB24-417A-9C74-100CC2D7001A

Q34102506-7BA7F12F-FA57-44A7-9974-1F320AA20404

Q34102506-A4FDAA6B-7B42-4638-8019-BEADF5227F05

Q34102506-AE295F14-8868-4A89-8103-3612DC3F0869

Q34102506-B34E7255-1E3D-4928-A923-2EDCDA2656BC

Q34102506-BE0F7BDD-9D19-47C2-9164-93A3DCAF0E49

P2860

Q34102506-00D17699-74E3-4005-A245-FE971637238A

Q34102506-0BA0D406-6D4C-4783-AC91-6931DE061160

Q34102506-1168CB71-C60C-4FBB-93E3-1F6B6E017A40

Q34102506-143D5E84-9EB7-4BDF-A01B-034306EC2E85

Q34102506-3DED55A3-EFE8-45EF-8FD7-4F7156CCDF34

Q34102506-40C28214-7DCF-466B-8A7B-0CBF122E5369

Q34102506-4AD0EA34-CFA7-4DBE-AD0B-DC272F006652

Q34102506-531AFC92-12DC-4A17-940A-BDBD3C5AF7E5

Q34102506-5AB8C275-19DA-441A-8EEE-BCAEE96F8913

Q34102506-5F620E77-197F-4A94-BE9E-0C7B31F6C585

P2888

Q34102506-FBBE6DAC-B888-4429-8361-0C668978209F

P304

Q34102506-D3CBF856-3AB7-4FFB-835A-6C3CDF6C7A20

P31

Q34102506-22384686-7CBC-419C-8727-7ED4874B2187

P356

Q34102506-3F822606-F364-43EA-8461-33B40CCE61F1

P433

Q34102506-ED00C846-DF26-446A-AEA2-82E2FC6CDF4B

P478

Q34102506-8AD9921C-6A34-430A-82DB-BFC38472ED62

P50

Q34102506-7266CE9E-E5A5-425E-A07E-EEF7F659998E

Q34102506-DB176141-5F80-4B11-AEFD-08B3FA6D271B

P577

Q34102506-BCBAAE03-FDF8-4F0E-91CD-30AE6AF2EE8B

P5875

Q34102506-4FE8D971-6811-4DE3-95D5-AC100E1790FE

P698

Q34102506-EE64A3B2-61FB-4F8B-8B7A-6F3548F7A868

P932

Q34102506-ABC0B484-F772-4337-AF3B-1DF2E5CD0556

P356

S00259-010-1489-Y

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

@en

P2093

Anneloes Y Rijnders

http://www.w3.org/2001/XMLSchema#string

Astrid A M van der Veldt

http://www.w3.org/2001/XMLSchema#string

Egbert F Smit

http://www.w3.org/2001/XMLSchema#string

Jacobus J M van der Hoeven

http://www.w3.org/2001/XMLSchema#string

Mark Lubberink

http://www.w3.org/2001/XMLSchema#string

Martien P J Mooijer

http://www.w3.org/2001/XMLSchema#string

N Harry Hendrikse

http://www.w3.org/2001/XMLSchema#string

Winald R Gerritsen

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103

Docetaxel for treatment of solid tumours: a systematic review of clinical data.

Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

An oncological view on the blood-testis barrier.

Automated synthesis of 18F analogue of paclitaxel (PAC): [18F]Paclitaxel (FPAC).

Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents.

Imaging multidrug resistance with 4-[18F]fluoropaclitaxel.

Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistance.

P2888

s00259-010-1489-y

P304

1950-1958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-010-1489-Y

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Albert D. Windhorst

Adriaan A Lammertsma

P577

2010-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44636474

http://www.w3.org/2001/XMLSchema#string

P698

20508935

http://www.w3.org/2001/XMLSchema#string

P932

2933032

http://www.w3.org/2001/XMLSchema#string